• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Replies
3
Views
466
Replies
9
Views
2K
Replies
35
Views
5K
Replies
187
Views
28K
Replies
5
Views
617